Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
€7,56 ↑0,24 (3,28%)
2026-06-05
HİSSE FİYATI
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionProsight Management, LP
Latest Disclosed Ownership3,356,700 shares
Latest Disclosed Value $ 27,289,971
Prosight Management, LP reports 32.70% increase in ownership of KUR / Kura Oncology, Inc.

On May 15, 2026 - Prosight Management, LP filed a 13F-HR form disclosing ownership of 3,356,700 shares of Kura Oncology, Inc. (DE:KUR) valued at $22,322,055 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,529,600 shares of Kura Oncology, Inc.. This represents a change in shares of 32.70% during the quarter. The current value of the position is $25,376,652 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KURA ONCOLOGY COM 50127T109 3,356,700 827,100 32.70 27,290 3.83 4.4751
2026-02-13 2025-12-31 13F KURA ONCOLOGY COM 50127T109 2,529,600 -228,916 -8.30 26,283 7.66 5.4311
2025-11-14 2025-09-30 13F KURA ONCOLOGY COM 50127T109 2,758,516 -422,668 -13.29 24,413 33.00 5.6936
2025-08-14 2025-06-30 13F KURA ONCOLOGY COM 50127T109 3,181,184 1,102,869 53.07 18,355 33.82 4.4763
2025-05-15 2025-03-31 13F KURA ONCOLOGY COM 50127T109 2,078,315 753,315 56.85 13,717 18.86 4.5070
2025-02-14 2024-12-31 13F KURA ONCOLOGY COM 50127T109 1,325,000 619,891 87.91 11,541 -16.24 3.1895
2024-11-14 2024-09-30 13F KURA ONCOLOGY COM 50127T109 705,109 75,209 11.94 13,778 6.23 3.3906
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM 50127T109 629,900 -330,100 -34.39 12,970 -36.66 3.8765
2024-05-15 2024-03-31 13F KURA ONCOLOGY COM 50127T109 960,000 10,000 1.05 20,477 49.89 5.6967
2024-02-14 2023-12-31 13F KURA ONCOLOGY COM 50127T109 950,000 -982,456 -50.84 13,661 -22.48 5.4845
2023-11-14 2023-09-30 13F KURA ONCOLOGY COM 50127T109 1,932,456 589,097 43.85 17,624 24.00 5.5853
2023-08-14 2023-06-30 13F/A-1 KURA ONCOLOGY COM 50127T109 1,343,359 1,343,359 14,213 4.1603
2023-08-14 2023-06-30 13F KURA ONCOLOGY COM 50127T109 1,343,359 1,343,359 14,213 4.3624
2021-02-12 2020-12-31 13F KURA ONCOLOGY COM 50127T109 0 -107,367 -100.00 0 -100.00
2020-11-13 2020-09-30 13F KURA ONCOLOGY COM 50127T109 107,367 -577,633 -84.33 3,290 -70.54 1.5648
2020-08-14 2020-06-30 13F KURA ONCOLOGY COM 50127T109 685,000 -765,000 -52.76 11,166 -22.61 4.7929
2020-05-15 2020-03-31 13F KURA ONCOLOGY COM 50127T109 1,450,000 414,000 39.96 14,428 1.28 6.7445
2020-02-14 2019-12-31 13F KURA ONCOLOGY COM 50127T109 1,036,000 147,848 16.65 14,245 5.73 6.2547
2019-11-14 2019-09-30 13F KURA ONCOLOGY COM 50127T109 888,152 20,342 2.34 13,473 -21.15 7.4735
2019-08-14 2019-06-30 13F KURA ONCOLOGY COM 50127T109 867,810 694,916 401.93 17,087 495.78 8.6154
2019-05-15 2019-03-31 13F KURA ONCOLOGY COM 50127T109 172,894 -143,687 -45.39 2,868 -35.48 1.2548
2019-02-14 2018-12-31 13F KURA ONCOLOGY COM 50127T109 316,581 62,950 24.82 4,445 0.14 2.2948
2018-11-14 2018-09-30 13F KURA ONCOLOGY COM 50127T109 253,631 -34,256 -11.90 4,439 -15.29 2.4752
2018-08-14 2018-06-30 13F KURA ONCOLOGY COM 50127T109 287,887 287,887 5,240 3.8415
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.